These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10608513)

  • 1. Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis.
    Curhan GC
    J Endourol; 1999 Nov; 13(9):629-31. PubMed ID: 10608513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis.
    Trinchieri A; Ostini F; Nespoli R; Rovera F; Zanetti G; Pisani E
    J Nephrol; 1998; 11 Suppl 1():70-2. PubMed ID: 9604817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
    Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes.
    Moyad MA
    Urol Nurs; 2003 Aug; 23(4):310-3. PubMed ID: 14552081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
    Siener R; Ebert D; Nicolay C; Hesse A
    Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of nephrolithiasis in France].
    Daudon M
    Ann Urol (Paris); 2005 Dec; 39(6):209-31. PubMed ID: 16425740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary calcium, dietary protein, and kidney stone formation.
    Curhan GC
    Miner Electrolyte Metab; 1997; 23(3-6):261-4. PubMed ID: 9387129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of stone disease.
    Delvecchio FC; Preminger GM
    Curr Opin Urol; 2003 May; 13(3):229-33. PubMed ID: 12692447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxaluric calcium nephrolithiasis.
    Asplin JR
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):927-49. PubMed ID: 12474639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of kidney stone formation: an analysis.
    Khan SR
    World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.